Published in Infect Immun on May 01, 1994
Cholera. Clin Microbiol Rev (1995) 12.33
Toxin-coregulated pilus, but not mannose-sensitive hemagglutinin, is required for colonization by Vibrio cholerae O1 El Tor biotype and O139 strains. Infect Immun (1996) 4.06
Identification of a vibrio cholerae RTX toxin gene cluster that is tightly linked to the cholera toxin prophage. Proc Natl Acad Sci U S A (1999) 3.75
Genesis of the novel epidemic Vibrio cholerae O139 strain: evidence for horizontal transfer of genes involved in polysaccharide synthesis. EMBO J (1995) 3.46
The Vibrio cholerae O139 serogroup antigen includes an O-antigen capsule and lipopolysaccharide virulence determinants. Proc Natl Acad Sci U S A (1994) 2.68
The capsule and O antigen in Vibrio cholerae O139 Bengal are associated with a genetic region not present in Vibrio cholerae O1. Infect Immun (1995) 2.25
Analysis of 16S-23S rRNA intergenic spacer regions of Vibrio cholerae and Vibrio mimicus. Appl Environ Microbiol (1999) 2.23
The mannose-sensitive hemagglutinin of Vibrio cholerae promotes adherence to zooplankton. Appl Environ Microbiol (2001) 2.23
Genetic rearrangements in the rfb regions of Vibrio cholerae O1 and O139. Proc Natl Acad Sci U S A (1995) 2.15
Vibrio cholerae O139 Bengal. J Clin Microbiol (1994) 2.07
Comparison of immune responses in patients infected with Vibrio cholerae O139 and O1. Infect Immun (1997) 2.01
The OmpU outer membrane protein, a potential adherence factor of Vibrio cholerae. Infect Immun (1995) 1.99
Serogroup conversion of Vibrio cholerae in aquatic reservoirs. PLoS Pathog (2007) 1.98
Investigation of the roles of toxin-coregulated pili and mannose-sensitive hemagglutinin pili in the pathogenesis of Vibrio cholerae O139 infection. Infect Immun (1998) 1.90
Comparison of the vibriocidal antibody response in cholera due to Vibrio cholerae O139 Bengal with the response in cholera due to Vibrio cholerae O1. Clin Diagn Lab Immunol (1995) 1.89
Emergence and evolution of Vibrio cholerae O139. Proc Natl Acad Sci U S A (2003) 1.83
Enterobacterial repetitive intergenic consensus sequences and the PCR to generate fingerprints of genomic DNAs from Vibrio cholerae O1, O139, and non-O1 strains. Appl Environ Microbiol (1995) 1.80
Evidence for the emergence of non-O1 and non-O139 Vibrio cholerae strains with pathogenic potential by exchange of O-antigen biosynthesis regions. Infect Immun (2002) 1.67
Novel Vibrio cholerae O139 genes involved in lipopolysaccharide biosynthesis. J Bacteriol (1997) 1.56
The Vibrio cholerae O139 O-antigen polysaccharide is essential for Ca2+-dependent biofilm development in sea water. Proc Natl Acad Sci U S A (2003) 1.54
Isolation and characterization of rugose form of Vibrio cholerae O139 strain MO10. Infect Immun (1999) 1.42
Association of Vibrio cholerae O1 El Tor and O139 Bengal with the Copepods Acartia tonsa and Eurytemora affinis. Appl Environ Microbiol (2007) 1.39
Phylogeny of Vibrio cholerae based on recA sequence. Infect Immun (2000) 1.37
Identification of additional genes required for O-antigen biosynthesis in Vibrio cholerae O1. J Bacteriol (1997) 1.24
Vibriocidal antibody responses in North American volunteers exposed to wild-type or vaccine Vibrio cholerae O139: specificity and relevance to immunity. Clin Diagn Lab Immunol (1997) 1.23
2,3-butanediol synthesis and the emergence of the Vibrio cholerae El Tor biotype. Infect Immun (2006) 1.22
Mucosal immunization with Vibrio cholerae outer membrane vesicles provides maternal protection mediated by antilipopolysaccharide antibodies that inhibit bacterial motility. Infect Immun (2010) 1.12
Immune mechanisms and protective antigens of Vibrio cholerae serogroup O139 as a basis for vaccine development. Infect Immun (1996) 1.11
Phage specific for Vibrio cholerae O139 Bengal. J Clin Microbiol (1996) 1.08
Distribution and virulence of Vibrio cholerae belonging to serogroups other than O1 and O139: a nationwide survey. Epidemiol Infect (1995) 1.08
Vibrio cholerae O139 requires neither capsule nor LPS O side chain to grow inside Acanthamoeba castellanii. J Med Microbiol (2009) 1.02
Transcutaneous immunization with a Vibrio cholerae O1 Ogawa synthetic hexasaccharide conjugate following oral whole-cell cholera vaccination boosts vibriocidal responses and induces protective immunity in mice. Clin Vaccine Immunol (2012) 1.02
Cloning and sequencing of the genes downstream of the wbf gene cluster of Vibrio cholerae serogroup O139 and analysis of the junction genes in other serogroups. Infect Immun (1999) 0.99
Susceptibility of Vibrio cholerae O139 to antibody-dependent, complement-mediated bacteriolysis. Clin Diagn Lab Immunol (2000) 0.98
Cloning and sequence of a region of Vibrio cholerae O139 Bengal and its use in PCR-based detection. J Clin Microbiol (1996) 0.98
Preliminary structure determination of the capsular polysaccharide of Vibrio cholerae O139 Bengal Al1837. J Bacteriol (1995) 0.98
Construction of a Vibrio cholerae vaccine candidate using transposon delivery and FLP recombinase-mediated excision. Infect Immun (2000) 0.98
Antibody against the capsule of Vibrio cholerae O139 protects against experimental challenge. Infect Immun (1996) 0.94
Structural and functional characterization of IS1358 from Vibrio cholerae. J Bacteriol (1998) 0.92
Phagocytosis of Vibrio cholerae O139 Bengal by human polymorphonuclear leukocytes. Clin Diagn Lab Immunol (1999) 0.85
Construction and characterization of a potential live oral carrier-based vaccine against Vibrio cholerae O139. Infect Immun (1996) 0.84
Diversity of Clinical and Environmental Isolates of Vibrio cholerae in Natural Transformation and Contact-Dependent Bacterial Killing Indicative of Type VI Secretion System Activity. Appl Environ Microbiol (2016) 0.82
The utility of human challenge studies in vaccine development: lessons learned from cholera. Vaccine (Auckl) (2011) 0.82
A molecular surveillance reveals the prevalence of Vibrio cholerae O139 isolates in China from 1993 to 2012. J Clin Microbiol (2014) 0.80
Critical analysis of compositions and protective efficacies of oral killed cholera vaccines. Clin Vaccine Immunol (2014) 0.79
Comparative genomics of 274 Vibrio cholerae genomes reveals mobile functions structuring three niche dimensions. BMC Genomics (2014) 0.77
Application of chitosan microparticles for reduction of vibrio species in seawater and live oysters (Crassostrea virginica). Appl Environ Microbiol (2014) 0.76
Non-O1 Vibrio cholerae. Lancet (1993) 3.45
Serotype conversion in Vibrio cholerae O1. Proc Natl Acad Sci U S A (1992) 3.00
Experimental non-O group 1 Vibrio cholerae gastroenteritis in humans. J Clin Invest (1990) 2.33
Non-O:1 Vibrio cholerae bacteremia: case report and review. Rev Infect Dis (1988) 2.07
Non-O1 Vibrio cholerae NRT36S produces a polysaccharide capsule that determines colony morphology, serum resistance, and virulence in mice. Infect Immun (1992) 1.86
Purification and determination of the structure of capsular polysaccharide of Vibrio vulnificus M06-24. J Bacteriol (1992) 1.81
Development and testing of a nonradioactive DNA oligonucleotide probe that is specific for Vibrio cholerae cholera toxin. J Clin Microbiol (1992) 1.71
Identification of Vibrio cholerae by enzyme electrophoresis. Trans R Soc Trop Med Hyg (1992) 1.55
Blood stream invasion by Vibrio cholerae O139. Lancet (1993) 1.26
Cholera. Clin Microbiol Rev (1995) 12.33
Epidemiology, genetics, and ecology of toxigenic Vibrio cholerae. Microbiol Mol Biol Rev (1998) 8.36
Large outbreak of clinical cholera due to Vibrio cholerae non-O1 in Bangladesh. Lancet (1993) 5.48
Cholera and other vibrioses in the United States. N Engl J Med (1985) 5.17
Bacteriophage therapy. Antimicrob Agents Chemother (2001) 5.16
Oxygen and the growth and metabolism of Clostridium acetobutylicum. J Gen Microbiol (1971) 4.91
Noncontact anterior cruciate ligament injuries: risk factors and prevention strategies. J Am Acad Orthop Surg (2000) 4.61
Volunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques. Infect Immun (1988) 4.44
Role of iron in the pathogenesis of Vibrio vulnificus infections. Infect Immun (1981) 4.42
Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension (2001) 4.41
Pandemic spread of an O3:K6 clone of Vibrio parahaemolyticus and emergence of related strains evidenced by arbitrarily primed PCR and toxRS sequence analyses. J Clin Microbiol (2000) 4.40
Emerging foodborne pathogens: Escherichia coli O157:H7 as a model of entry of a new pathogen into the food supply of the developed world. Epidemiol Rev (1996) 4.09
Harlequin syndrome: the sudden onset of unilateral flushing and sweating. J Neurol Neurosurg Psychiatry (1988) 3.47
Phenotypic evaluation of acapsular transposon mutants of Vibrio vulnificus. Infect Immun (1990) 3.47
Non-O group 1 Vibrio cholerae gastroenteritis in the United States: clinical, epidemiologic, and laboratory characteristics of sporadic cases. Ann Intern Med (1981) 3.25
Learning and memory difficulties after environmental exposure to waterways containing toxin-producing Pfiesteria or Pfiesteria-like dinoflagellates. Lancet (1998) 3.03
Safety, infectivity, immunogenicity, and in vivo stability of two attenuated auxotrophic mutant strains of Salmonella typhi, 541Ty and 543Ty, as live oral vaccines in humans. J Clin Invest (1987) 3.03
Transcription of Ti plasmid-derived sequences in three octopine-type crown gall tumor lines. Proc Natl Acad Sci U S A (1979) 2.83
A new route of transmission for Escherichia coli: infection from dry fermented salami. Am J Public Health (1996) 2.78
Local hyperthermia in combination with definitive radiotherapy: increased tumor clearance, reduced recurrence rate in extended follow-up. Int J Radiat Oncol Biol Phys (1984) 2.72
Prevalence of toxin types and colonization factors in enterotoxigenic Escherichia coli isolated during a 2-year period from diarrheal patients in Bangladesh. J Clin Microbiol (2000) 2.69
In vitro activity of LY333328, an investigational glycopeptide antibiotic, against enterococci and staphylococci. Antimicrob Agents Chemother (1996) 2.63
Evaluation of DNA colony hybridization and other techniques for detection of virulence in Yersinia species. J Clin Microbiol (1989) 2.58
Production of Solvents by Clostridium acetobutylicum Cultures Maintained at Neutral pH. Appl Environ Microbiol (1984) 2.51
Factors effecting late results after meniscectomy. J Bone Joint Surg Am (1974) 2.49
Back pain: a randomized clinical trial of rotational manipulation of the trunk. Br J Ind Med (1974) 2.47
Identification and cloning of a novel plasmid-encoded enterotoxin of enteroinvasive Escherichia coli and Shigella strains. Infect Immun (1995) 2.45
Cloning of the cytotoxin-hemolysin gene of Vibrio vulnificus. Infect Immun (1985) 2.42
Stool microflora in extremely low birthweight infants. Arch Dis Child Fetal Neonatal Ed (1999) 2.41
Excessive fructose intake induces the features of metabolic syndrome in healthy adult men: role of uric acid in the hypertensive response. Int J Obes (Lond) (2009) 2.39
On the permeability to weak acids and bases of the cytoplasmic membrane of Clostridium pasteurianum. Biochem Biophys Res Commun (1981) 2.32
Evidence of high-frequency genomic reassortment of group A rotavirus strains in Bangladesh: emergence of type G9 in 1995. J Clin Microbiol (1999) 2.31
The capsule and O antigen in Vibrio cholerae O139 Bengal are associated with a genetic region not present in Vibrio cholerae O1. Infect Immun (1995) 2.25
Isolation of enterotoxigenic Bacteroides fragilis from Bangladeshi children with diarrhea: a controlled study. J Clin Microbiol (1994) 2.23
The use of health services by older adults. J Gerontol (1991) 2.18
Illness caused by Vibrio damsela and Vibrio hollisae. Lancet (1982) 2.17
Vibrio cholerae O1 can assume a chlorine-resistant rugose survival form that is virulent for humans. J Infect Dis (1996) 2.17
Genetic rearrangements in the rfb regions of Vibrio cholerae O1 and O139. Proc Natl Acad Sci U S A (1995) 2.15
Prospective study of follow up alone in stage I teratoma of the testis. Br Med J (Clin Res Ed) (1983) 2.13
Isolation of vancomycin-resistant enterococci from animal feed in USA. Lancet (1999) 2.12
Distribution of Vibrio vulnificus in the Chesapeake Bay. Appl Environ Microbiol (1996) 2.10
The sydney multicentre study of Parkinson's disease: progression and mortality at 10 years. J Neurol Neurosurg Psychiatry (1999) 2.07
Non-O:1 Vibrio cholerae bacteremia: case report and review. Rev Infect Dis (1988) 2.07
Production, characterization, and application of monoclonal antibodies to Vibrio cholerae O139 synonym Bengal. Clin Diagn Lab Immunol (1994) 2.07
Half-time and high-speed running in the second half of soccer. Int J Sports Med (2012) 2.03
Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model. Kidney Int (1992) 2.02
Cloning and sequence of a region encoding a surface polysaccharide of Vibrio cholerae O139 and characterization of the insertion site in the chromosome of Vibrio cholerae O1. Mol Microbiol (1996) 2.01
Comparison of immune responses in patients infected with Vibrio cholerae O139 and O1. Infect Immun (1997) 2.01
Mechanical changes in the knee after meniscectomy. J Bone Joint Surg Am (1976) 2.00
Analysis of clinical and environmental strains of nontoxigenic Vibrio cholerae for susceptibility to CTXPhi: molecular basis for origination of new strains with epidemic potential. Infect Immun (1998) 1.99
Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1. J Am Soc Nephrol (2001) 1.98
Comparison of DNA probes and the Sereny test for identification of invasive Shigella and Escherichia coli strains. J Clin Microbiol (1986) 1.96
Strain within the anterior cruciate ligament during hamstring and quadriceps activity. Am J Sports Med (1986) 1.95
Utilization of L-threonine by a species of Arthrobacter. A novel catabolic role for "aminoacetone synthase". Biochem J (1969) 1.95
Rapid identification of Vibrio vulnificus on nonselective media with an alkaline phosphatase-labeled oligonucleotide probe. Appl Environ Microbiol (1993) 1.94
Identification of environmental Vibrio vulnificus isolates with a DNA probe for the cytotoxin-hemolysin gene. Appl Environ Microbiol (1987) 1.94
Induction of beta-platelet-derived growth factor receptor in rat hepatic lipocytes during cellular activation in vivo and in culture. J Clin Invest (1994) 1.91
Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function. J Am Soc Nephrol (2001) 1.90
Comparison of the vibriocidal antibody response in cholera due to Vibrio cholerae O139 Bengal with the response in cholera due to Vibrio cholerae O1. Clin Diagn Lab Immunol (1995) 1.89
The extracellular cytolysin of Vibrio vulnificus: inactivation and relationship to virulence in mice. Infect Immun (1991) 1.87
Trends in skiing injuries. Analysis of a 6-year study (1972 to 1978). Am J Sports Med (1980) 1.86
Non-O1 Vibrio cholerae NRT36S produces a polysaccharide capsule that determines colony morphology, serum resistance, and virulence in mice. Infect Immun (1992) 1.86
The risk of nursing home placement and subsequent death among older adults. J Gerontol (1992) 1.86
Superoxide dismutase in some obligately anaerobic bacteria. FEBS Lett (1975) 1.85
Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo. Am J Pathol (1998) 1.83
Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J Clin Invest (1994) 1.83
Characterization of Vibrio cgolerae non-O1 serogroups obtained from an outbreak of diarrhea in Lima, Peru. J Clin Microbiol (1995) 1.82
Induction of the lysogenic phage encoding cholera toxin in naturally occurring strains of toxigenic Vibrio cholerae O1 and O139. Infect Immun (1998) 1.81
Purification and determination of the structure of capsular polysaccharide of Vibrio vulnificus M06-24. J Bacteriol (1992) 1.81
Molecular analysis of rRNA and cholera toxin genes carried by the new epidemic strain of toxigenic Vibrio cholerae O139 synonym Bengal. J Clin Microbiol (1994) 1.79
The cytolysin gene of Vibrio vulnificus: sequence and relationship to the Vibrio cholerae E1 Tor hemolysin gene. Infect Immun (1990) 1.79
Clinical and immunologic characteristics of Vibrio cholerae O139 Bengal infection in North American volunteers. J Infect Dis (1995) 1.75
New mechanism for glomerular injury. Myeloperoxidase-hydrogen peroxide-halide system. J Clin Invest (1987) 1.75
A "weight-listing" paradox for candidates of renal transplantation? Am J Transplant (2006) 1.75
Risk factors and mortality associated with calciphylaxis in end-stage renal disease. Kidney Int (2001) 1.75
Aetiology of acute gastroenteritis in infancy and early childhood in southern India. Arch Dis Child (1977) 1.74
Facial sweating in Horner's syndrome. Brain (1984) 1.73
The significance of residual mediastinal abnormality on the chest radiograph following treatment for Hodgkin's disease. J Clin Oncol (1988) 1.73
Vascular endothelial growth factor accelerates renal recovery in experimental thrombotic microangiopathy. Kidney Int (2000) 1.72
Molecular epidemiology of toxigenic Vibrio cholerae in Bangladesh studied by numerical analysis of rRNA gene restriction patterns. J Clin Microbiol (1995) 1.72
Development and testing of a nonradioactive DNA oligonucleotide probe that is specific for Vibrio cholerae cholera toxin. J Clin Microbiol (1992) 1.71
Investigation of an outbreak of Salmonella enteritidis gastroenteritis associated with consumption of eggs in a restaurant chain in Maryland. Am J Epidemiol (1988) 1.71
Changes in functional status and the risks of subsequent nursing home placement and death. J Gerontol (1993) 1.71
Molecular techniques in the study of Salmonella typhi in epidemiologic studies in endemic areas: comparison with Vi phage typing. Am J Trop Med Hyg (1986) 1.68
The strain behavior of the anterior cruciate ligament during squatting and active flexion-extension. A comparison of an open and a closed kinetic chain exercise. Am J Sports Med (1998) 1.68
Seroprevalence of Helicobacter pylori in Seventh-Day Adventists and other groups in Maryland. Lack of association with diet. Arch Intern Med (1990) 1.68
Perceived health status and mortality among older men and women. J Gerontol (1992) 1.67
Gastrostomy insertion: comparing the options--PEG, RIG or PIG? Clin Radiol (2003) 1.67
Thiazide-induced subtle renal injury not observed in states of equivalent hypokalemia. Kidney Int (2007) 1.66
Improved pulsed-field gel electrophoresis for typing vancomycin-resistant enterococci. J Clin Microbiol (2000) 1.66
Cholera in Lima, Peru, correlates with prior isolation of Vibrio cholerae from the environment. Am J Epidemiol (1997) 1.65